Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey D Barnes

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
Blood Advances|January 20, 2022
Management strategies following slightly out-of-range INRs: watchful waiting vs dose changesHallie B Remer, Xiaokui Gu, Brian Haymart, et al.
Pulmonary Circulation|January 12, 2019
EXPRESS: A Multidisciplinary Pulmonary Embolism Response Team (PERT) - Experience from a national multicenter consortiumJacob Schultz, Nicholas Giordano, Hui Zheng, et al.
Blood Advances|October 7, 2024
Guideline concordance of aspirin use for primary prevention in adult outpatientsNaina Chipalkatti, Geoffrey D Barnes, Linda Bashaw, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2023
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of AnticoagulationGeoffrey D Barnes, Walter Ageno, Lana A Castellucci, et al.
Annals of the American Thoracic Society|August 9, 2023
Sex, Racial, and Geographic Disparities in Pulmonary Embolism-related Mortality NationwideMohamed Zghouzi, Hunter Mwansa, Supriya Shore, et al.
Circulation. Cardiovascular Quality and Outcomes|June 2, 2016
Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramGeoffrey D Barnes, Maggie A Stanislawski, Wenhui Liu, et al.
JAMA Internal Medicine|March 5, 2019
Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse EventsJordan K Schaefer, Yun Li, Xiaokui Gu, et al.
Thrombosis and Haemostasis|November 25, 2016
Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH ScoreSaurav Chatterjee, Ido Weinberg, Robert W Yeh, et al.
JAMA Network Open|March 19, 2026
Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical TrialDaniel M Witt, Heeseung Hong, Aaron S Wilson, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Blood Advances|January 20, 2022
Management strategies following slightly out-of-range INRs: watchful waiting vs dose changesHallie B Remer, Xiaokui Gu, Brian Haymart, et al.
Pulmonary Circulation|January 12, 2019
EXPRESS: A Multidisciplinary Pulmonary Embolism Response Team (PERT) - Experience from a national multicenter consortiumJacob Schultz, Nicholas Giordano, Hui Zheng, et al.
Blood Advances|October 7, 2024
Guideline concordance of aspirin use for primary prevention in adult outpatientsNaina Chipalkatti, Geoffrey D Barnes, Linda Bashaw, et al.
Research and Practice in Thrombosis and Haemostasis|October 15, 2024
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolismScott C Woller, Scott M Stevens, Joseph R Bledsoe, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2023
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of AnticoagulationGeoffrey D Barnes, Walter Ageno, Lana A Castellucci, et al.
Annals of the American Thoracic Society|August 9, 2023
Sex, Racial, and Geographic Disparities in Pulmonary Embolism-related Mortality NationwideMohamed Zghouzi, Hunter Mwansa, Supriya Shore, et al.
Circulation. Cardiovascular Quality and Outcomes|June 2, 2016
Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramGeoffrey D Barnes, Maggie A Stanislawski, Wenhui Liu, et al.
JAMA Internal Medicine|March 5, 2019
Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse EventsJordan K Schaefer, Yun Li, Xiaokui Gu, et al.
Thrombosis and Haemostasis|November 25, 2016
Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH ScoreSaurav Chatterjee, Ido Weinberg, Robert W Yeh, et al.
JAMA Network Open|March 19, 2026
Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical TrialDaniel M Witt, Heeseung Hong, Aaron S Wilson, et al.
Pageof 30